Plaintiffs ask US appeals court to affirm class cert in pharma antitrust litigation
MLex Summary: Plaintiffs bringing US antitrust claims against Actavis and Mylan over generic pharmaceuticals told a federal appeals court that the district court correctly applied the appropriate standard to an airtight...To view the full article, register now.
Already a subscriber? Click here to view full article